Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-07-25
2006-07-25
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S785000
Reexamination Certificate
active
07081445
ABSTRACT:
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.
REFERENCES:
patent: 3288824 (1966-11-01), Mahler et al.
patent: 4073920 (1978-02-01), Dowrick
patent: 4108985 (1978-08-01), Ruegger et al.
patent: 4210581 (1980-07-01), Ruegger et al.
patent: 4220641 (1980-09-01), Traber et al.
patent: 4388307 (1983-06-01), Cavanak
patent: 4390548 (1983-06-01), Yamato et al.
patent: 4719239 (1988-01-01), Muller et al.
patent: 4990337 (1991-02-01), Kurihara et al.
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5338761 (1994-08-01), Nakajima et al.
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5639724 (1997-06-01), Cavanak
patent: 5652212 (1997-07-01), Cavanak et al.
patent: 5759997 (1998-06-01), Cavanak
patent: 5916589 (1999-06-01), Hauer et al.
patent: 5977066 (1999-11-01), Cavanak
patent: 6262022 (2001-07-01), Hauer et al.
patent: 6306825 (2001-10-01), Cavanak
patent: 6468968 (2002-10-01), Cavanak et al.
patent: 895724 (1983-07-01), None
patent: 2461/78-6 (1983-06-01), None
patent: 8634/78-8 (1983-06-01), None
patent: 641356 (1984-02-01), None
patent: 0170623 (1986-02-01), None
patent: 2098865 (1982-12-01), None
patent: 2120935 (1983-12-01), None
patent: 2211848 (1989-07-01), None
Chemical Abstract 92:64765k (1980).
Cavanak et al., Prog. Allergy, vol. 38, pp. 65-72 j(1986).
Eckert et al., Chemical Abstracts, 89: 117875t (Jun. 8, 1978).
Chemical Abstracts, 89: 117874s (Jun. 8, 1978).
Takada et al., Int. J. of Pharmaceuticals vol. 44; 107-116 (1988).
Chemical Abstracts, 95: 225610K (1981).
Simpson et al., Chemical Abstracts 94: 327C (1981).
Takada et al., J. Pharmacobio-Dyn. vol. 11: 80-87 (1988).
Reymond et al., Pharmaceutical Research, vol. 5, No. 10, pp. 673-676 (1988).
Reymond, University of Basel (1986) Dissertation: In vitro in Vivo Model for the Absorption of Cyclosporin A.
Cavanak, Chemical Abstracts, 92: 64765k (1980).
Derwent Abstracts, 84-069426/12 (Feb. 19, 1984). (Abstract of JA 61/280,435, Published Dec. 11, 1986).
Miglyol-Neutral Oil, Dynamit Nobel Chemicals (1975).
Cavanak Thomas
Posanski Ulrich
Novartis AG
Russel Jeffrey Edwin
Savitsky Thomas R.
LandOfFree
Cyclosporin galenic forms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclosporin galenic forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin galenic forms will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3571024